Pearl River Capital, LLC Invitae Corp Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $82,085 - $203,776	-13,071 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$14.7 - $28.67 $192,143 - $374,745	13,071 New	13,071 $200,000
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $152,783 - $236,582	-5,856 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.06 - $56.93 $158,555 - $273,036	-4,796 Reduced 45.02%	5,856 $224,000
Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $416,386 - $611,424	10,652 New	10,652 $445,000

Q2 2019 Aug 12, 2019	SELL	$17.37 - $26.27 $34 - $52	-2 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$10.65 - $25.75 $21 - $51	2 New	2 $0

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.